IDiyas

For the Inventor, By the Inventor

Rødovre, Denmark

John Paul Redrobe

USPTO Granted Patents = 19 

 

Average Co-Inventor Count = 4.3

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • Copenhagen, DK (2010)
  • København K, DK (2010)
  • København, DK (2010 - 2011)
  • Rodovre, DK (2011)
  • Kobenhavn K, DK (2011)
  • Rødovre, DK (2009 - 2013)

Company Filing History:

goldMedal19 out of 206 
 
Neurosearch A/s
 patents

Years Active: 2009-2013

Loading Chart...
Loading Chart...
19 patents (USPTO):Explore Patents
1. 8372832 - 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl compounds and their medical use (2013-02-12),
2. 8343960 - 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidine derivatives and their medical use (2013-01-01),
3. 8263617 - Chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors (2012-09-11),
4. 8158619 - 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl compounds and their medical use (2012-04-17),
5. 8153797 - Chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors (2012-04-10),
6. 8110586 - 8-aza-bicyclo[3.2.1]octane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors (2012-02-07),
7. 8093388 - 3-aza spiro[5,5]undec-8-ene derivatives and their use as monoamine neurotransmitter re-uptake inhibitors (2012-01-10),
8. 8071598 - 3,9-diazabicyclo[3.3.1]nonane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors (2011-12-06),
9. 8049012 - 3-aza-spiro[5.5]undecane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors (2011-11-01),
10. 7994156 - Carboxylic acid 4-phenylazo-phenyl ester derivatives and their use as monoamine neurotransmitter re-uptake inhibitors (2011-08-09),
11. 7989470 - 3,8-substituted 8-aza-bicyclo[3.2.1]octane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors (2011-08-02),
12. 7943630 - 3,9-diaza-spiro[5.5]undecane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors (2011-05-17),
13. 7923444 - Alkyl substituted homopiperazine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors (2011-04-12),
14. 7781456 - Enantiomers of 3-heteroaryl-8H-8-azabicyclo(3.2.1)oct-2-ene and their use as monoamine neurotransmitter re-uptake inhibitors (2010-08-24),
15. 7713990 - 3,8-substituted 8-AZA-bicyclo[3.2.1]octane derivatives and their use as monomine neurotransmitter re-uptake inhibitors (2010-05-11),

Title: Innovations in Pharmaceutical Chemistry by John Paul Redrobe

Introduction

John Paul Redrobe is a prolific inventor based in Rødovre, Denmark, with an impressive portfolio of 19 patents. His work primarily focuses on novel pharmaceutical compounds, aimed at addressing a range of medical disorders. Through these innovations, Redrobe has significantly contributed to the fields of pharmacology and medicinal chemistry.

Latest Patents

Among his latest contributions are the patents for 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl compounds and 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidine derivatives. Both inventions revolve around unique derivatives that serve as cholinergic ligands at nicotinic acetylcholine receptors. These compounds are characterized by their ability to modulate monoamine receptors and transporters, presenting potential therapeutic uses in several medical conditions. The pharmacological profile of these derivatives suggests they could be beneficial in treating disorders connected to the cholinergic system of both the central and peripheral nervous systems, smooth muscle contractions, endocrine-related issues, neurodegenerative diseases, inflammation, pain management, and withdrawal symptoms from substance abuse.

Career Highlights

John Paul Redrobe showcases his expertise at Neurosearch A/s, a company dedicated to advancing drug discovery and development. His commitment to innovation in the pharmaceutical industry is reflected not only in his extensive patent portfolio but also in his ongoing research and development efforts.

Collaborations

Redrobe is known for collaborating with esteemed professionals in the industry, including colleagues Dan Peters and Elsebet Østergaard Nielsen. Together, they work on innovative solutions that bridge the gap between research and effective therapeutics, driving advances in medical science.

Conclusion

With 19 patents to his name, John Paul Redrobe continues to make significant contributions to pharmaceutical chemistry. His inventions represent a promising frontier in the treatment of various medical conditions, showcasing the impact of innovative research in the pursuit of better healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…